United States President Donald Trump stated on Monday that an announcement on auto tariffs will be made in the near future, with pharmaceutical industry tariffs expected to follow shortly thereafter. The remarks came during a cabinet meeting where Trump outlined his administration’s ongoing efforts to support domestic industry and reduce dependence on foreign imports.

Although no exact timeline was provided, Trump said the auto tariffs would come “very soon.” He described the move as part of a broader strategy to enhance U.S. manufacturing and promote economic self-reliance. The upcoming pharmaceutical levies are planned as a next step in the administration’s trade approach.

“We’ll be making the auto tariff announcement very soon, and pharmaceuticals after that,” Trump said. He noted that these tariffs are designed to protect U.S. industry while maintaining low domestic tax rates, positioning tariffs as a critical economic tool rather than a burden.

Trump also emphasized that previous tariff measures have already resulted in a significant reshoring of businesses to the United States. He claimed that his administration has possibly driven around $4 trillion worth of companies to return or plan to return operations to U.S. soil.

Auto and pharmaceutical tariffs have long been topics of interest in trade and economic discussions, with supporters arguing they protect American jobs and industries, while critics warn of potential consumer price increases and global trade tensions. Trump’s renewed focus signals that these sectors remain central to his economic agenda as his administration seeks to recalibrate U.S. trade balances.

Industry analysts and international trade partners are expected to closely watch the rollout of these tariffs and their potential impact on both the domestic economy and global supply chains. Until then, the U.S. business community awaits further details regarding implementation and scope.